Patient-level meta-analysis of 999 claudicants undergoing primary femoropopliteal nitinol stent implantation.
Krishna J Rocha-SinghJoshua A BeckmanGary AnselSean P LydenPeter SchneiderManish MehtaMichael DakeChristopher M MullinMichael R Jaffnull nullPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2017)
The 12-month clinical effectiveness of bare nitinol stents to treat patients with symptomatic femoropopliteal PAD is acceptable and is impacted by clinical and lesion-specific characteristics. These data provide an important and useful benchmark to compare the clinical benefit of emerging endovascular PAD therapies. © 2017 Wiley Periodicals, Inc.